Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias. - Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA (BMC medical genomics, 2020)